FTC Slams Surescripts for “Illegal Monopolization” of Two e-Prescription Drug Markets
The Federal Trade Commission recently filed a proposed order that would prohibit health information technology company Surescripts from engaging in exclusionary conduct and executing or enforcing non-compete agreements with current and …
FTC Slams Surescripts for “Illegal Monopolization” of Two e-Prescription Drug Markets Read More